Lipid Nanoparticle Delivery Technology

We have collected information about Lipid Nanoparticle Delivery Technology for you. Follow the links to find out details on Lipid Nanoparticle Delivery Technology.


Lipid Nanoparticles - Precision Nanosystems

    https://www.precisionnanosystems.com/areas-of-interest/formulations/lipid-nanoparticles
    Lipid nanoparticles (LNPs) are the most clinically advanced non-viral gene delivery system. Lipid nanoparticles safely and effectively deliver nucleic acids, overcoming a major barrier preventing the development and use of genetic medicines. Genetic medicine has many different applications such as gene editing, rapid vaccine development, immuno-oncology and treatment of rare genetic and ...

Lipid Nanoparticles - Acuitas

    https://acuitastx.com/technology/lipid-nanoparticles/
    Acuitas specializes in the development of lipid nanoparticle delivery systems for molecular therapeutics. Our scientists have synthesized over 500 novel cationic lipids which have been evaluated in in vivo models. This evaluation characterizes the potency and safety of these LNP carriers for delivery of nucleic acids payloads including siRNA, mRNA, plasmid and antisense oligonucleotides.

Modular lipid nanoparticle platform technology for siRNA ...

    https://www.biorxiv.org/content/10.1101/2020.01.16.907394v1
    Jan 16, 2020 · Successfully employing therapeutic nucleic acids, such as small interfering RNA (siRNA), requires chemical modifications or the use of nanocarrier technology to prevent their degradation in the circulation and to facilitate intracellular delivery. Lipid nanoparticles (LNP) are among the most advanced nanocarriers culminating in the first siRNA therapeutic’s clinical translation and approval ...Author: Roy van der Meel, Roy van der Meel, Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Xu...

Lipid Nanoparticle Technology for Clinical Translation of ...

    https://pubs.acs.org/doi/10.1021/acs.accounts.9b00368
    For efficient therapeutic siRNA delivery to hepatocytes, patisiran is critically dependent on lipid nanoparticle (LNP) technology.In this Account, we provide an overview of key advances that have been crucial for developing LNP delivery technology, and we explain how these developments have contributed to the clinical translation of siRNA ...Author: Jayesh A. Kulkarni, Dominik Witzigmann, Sam Chen, Pieter R. Cullis, Roy van der Meel, Roy van der Me...

Precision NanoSystems - Create Transformative Medicines

    https://www.precisionnanosystems.com/
    Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics . ... NxGen technology is at the heart of the NanoAssemblr® family, ... Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo . N. Jyotsana, A. Sharma, A. Chaturvedi, et al. ...

Our Platforms - Genevant

    https://genevant.com/platforms/
    Our industry-leading lipid nanoparticle (LNP) platform has enabled clinical development of the most advanced RNA-based therapeutics. Our LNP platform is the only clinically-validated LNP delivery technology with safety and efficacy evaluated in over 400 patients across multiple clinical programs.

Lipid Nanoparticle Technology for Clinical Translation of ...

    https://www.ncbi.nlm.nih.gov/pubmed/31397996
    Sep 17, 2019 · Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics. ... Finally, we highlight patisiran's clinical translation and LNP delivery technology's potential to enable the development of genetic drugs beyond the current state-of-the-art, such as …Author: Jayesh A. Kulkarni, Dominik Witzigmann, Sam Chen, Pieter R. Cullis, Roy van der Meel, Roy van der Me...

NANOPARTICLES - Drug Development and Delivery

    https://drug-dev.com/nanoparticles-a-revolution-in-the-development-of-drug-delivery-vehicles/
    The versatility of the NanoAssemblr technology means that it can also be applied to a variety of nanoparticle systems – liposomes, lipid nanoparticles, polymer particles, and micelles – offering research and development scientists the flexibility to explore a wide range of drug delivery mechanisms.

PAT for Liposomes and Lipid Nanoparticles

    https://www.news-medical.net/whitepaper/20200130/Liposome-and-Lipid-Nanoparticle-for-Drug-Delivery-Applications.aspx
    In liposome and lipid nanoparticle (LNP) drug-delivery applications, particle size is an important quality attribute (CQA) that can impact retention time, bioaccessibility and biodistribution.Author: Wyatt Technology

Searching for Lipid Nanoparticle Delivery Technology?

You can just click the links above. The data is collected for you.

Related Delivery Info